SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD
SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 4 — Sick Visit — Theodore Roosevelt
| Patient | Theodore Roosevelt |
|---|
| Date of birth | 2002-10-27 |
|---|
| Identifiers | MRN HR-NI012-SYN; SSN (made up) 000-12-6157 |
|---|
| Document date | 2026-08-03 |
|---|
| Author | Amos Kettering, MD |
|---|
| Custodian | St. Posthumous Health Center |
|---|
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Chief Complaint
Head cold for three days, now with wheeze and chest tightness. [S]
History of Present Illness
Mr. Roosevelt is a 23-year-old man with moderate persistent asthma, well controlled since spring on budesonide-formoterol maintenance-and-reliever therapy (two inhalations twice daily plus as needed), who asked for a same-day visit. Three days ago he developed a runny nose and sore throat after a week of late sessions; a colleague had a cold. Since yesterday he has had wheeze, chest tightness, and a dry cough that woke him twice last night. He followed the yellow zone of his action plan: he has taken 8 reliever inhalations a day on top of his maintenance doses, which help for two to three hours. His home peak flow has been 400 to 440 L/min, against a personal best of 610. A home COVID-19 antigen test this morning was negative. He has not boxed or rowed for two days. He has had no fever above 37.8 °C, no chest pain, and no breathlessness at rest. [S]
| Element | Detail |
|---|
| Onset | Cold symptoms three days ago; wheeze since yesterday |
| Severity | Moderate: talks in sentences, peak flow about 70 percent of personal best, night waking twice |
| Reliever use | 8 inhalations a day of budesonide-formoterol in addition to maintenance, within the 12-a-day maximum |
| Action plan | Yellow zone followed correctly; called as the plan instructs when not back in the green zone within 48 hours |
| Context | Viral cold; colleague ill; long working days |
| Pertinent negatives | No fever above 37.8 °C, chest pain, sputum change, or breathlessness at rest; COVID-19 antigen test negative |
| Exacerbation history | One oral corticosteroid course from urgent care last winter, before controller therapy; no emergency visits or hospital stays |
Review of Systems
| System | Result | Finding |
|---|
| Constitutional | Positive | Tired; temperature up to 37.8 °C; no chills |
| Ears, nose, mouth, and throat | Positive | Clear rhinorrhea and sore throat; no ear or facial pain |
| Respiratory | Positive | Wheeze, chest tightness, and dry cough, worse at night; no hemoptysis |
| Cardiovascular | Negative | No chest pain or palpitations beyond a fast pulse after reliever doses |
| Gastrointestinal | Negative | No nausea, vomiting, or reflux symptoms |
5 systems reviewed. [S]
Medications
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|
| Albuterol 90 mcg/actuation inhaler, two inhalations as needed for wheeze (bought after an urgent care visit; used most days before intake) | Two inhalations every 4 hours as needed | Respiratory tract route | 2025-12-15 to 2026-03-09 | stopped | S |
| Budesonide-formoterol 160/4.5 mcg inhaler, two inhalations twice daily for maintenance | Two inhalations twice daily, with a spacer, rinsing the mouth afterwards | Respiratory tract route | 2026-03-09 | active | S |
| Budesonide-formoterol 160/4.5 mcg inhaler, one inhalation as needed for symptoms and before exercise; no more than 12 inhalations a day in total | One inhalation as needed, repeated after a few minutes if needed; maximum 12 inhalations a day including maintenance doses | Respiratory tract route | 2026-03-09 | active | S |
| Prednisone 20 mg oral tablet, two tablets (40 mg) by mouth each morning for 5 days | Two tablets by mouth each morning for 5 days | Oral route | 2026-08-03 to 2026-08-07 | completed | S |
Allergies and Intolerances
| Allergy | Reaction | Status | Evidence |
|---|
| No known allergy | | active | S |
Vital Signs
| Date | Measure | Value | Unit | Provenance |
| 2026-08-03 | Body height | 175 | cm | S |
| 2026-08-03 | Body weight | 72.2 | kg | S |
| 2026-08-03 | Body mass index (BMI) [Ratio] | 23.6 | kg/m2 | S |
| 2026-08-03 | Systolic blood pressure | 122 | mm[Hg] | S |
| 2026-08-03 | Diastolic blood pressure | 76 | mm[Hg] | S |
| 2026-08-03 | Heart rate | 98 | /min | S |
| 2026-08-03 | Respiratory rate | 20 | /min | S |
| 2026-08-03 | Body temperature | 37.6 | Cel | S |
| 2026-08-03 | Oxygen saturation in Arterial blood by Pulse oximetry | 95 | % | S |
Results
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
| 2026-08-03 | Maximum expiratory gas flow Respiratory system airway by Peak flow meter | 420 | L/min | 80 percent or more of his personal best of 610 L/min (green zone) | Low | S |
Physical Exam
Vital signs recorded on 2026-08-03; see the Vital Signs section. [S]
| System | Finding |
|---|
| General | Alert, talking in full sentences, sitting comfortably; not using accessory muscles |
| Ears, nose, and throat | Red, swollen nasal mucosa with clear discharge; pharynx mildly red without exudate |
| Respiratory | Respiratory rate 20; scattered expiratory wheeze in both lungs with a prolonged expiratory phase; no crackles or focal dullness; peak flow 420 L/min |
| Cardiovascular | Heart rate 98, regular; no murmur |
| Mouth | No oral thrush |
Problems
| Problem | Clinical status | Verification | Code | Provenance |
| Moderate persistent asthma, uncontrolled at intake, with reversible airflow obstruction on spirometry; synthetic modern diagnosis linked to his documented lifelong asthma | active | confirmed |
J45.40 | S — Synthetic modern classification confirmed by spirometry; the historical asthma is D and its persistence into adulthood is R. |
| Myopia, both eyes, corrected with glasses since boyhood | active | confirmed |
H52.13 | S — Synthetic modern entry linked to his documented near-sightedness. |
| Moderate asthma exacerbation triggered by a viral cold, treated in the office with a five-day prednisone course; resolved | resolved | confirmed |
J45.41 | S — Synthetic exacerbation at an unscheduled visit; viral infection is the most common trigger of asthma exacerbations. It does not echo a dated historical episode. |
Assessment and Plan
- Moderate asthma exacerbation triggered by a viral cold (J45.41). Peak flow 420 L/min, 69 percent of personal best, with oxygen saturation 95 percent and no features of a severe or life-threatening attack. Two days of increased reliever use have not brought him back to the green zone, so a short oral corticosteroid course is indicated. No signs of pneumonia, so a chest radiograph and antibiotics are not indicated. [S]
- Prednisone 40 mg each morning for 5 days, with food; no taper needed for a short course.
- Continue budesonide-formoterol two inhalations twice daily, and one inhalation as needed, up to 12 in total a day.
- Inhaler technique checked with his own device and spacer: correct.
- Rest from boxing and hard rowing until peak flow is back above 488 L/min.
- Action plan updated: return or go to the emergency department for breathlessness at rest, peak flow below 305 L/min (50 percent), needing more than 12 inhalations a day, or poor relief.
- Moderate persistent asthma (J45.40). Well controlled before this cold. This is his first exacerbation since starting controller therapy, and it raises his future exacerbation risk. [S]
- Clinic review within one week of this exacerbation, by the CMID schedule.
- Influenza vaccine as soon as this season's vaccine arrives.
Guideline basis: Global Strategy for Asthma Management and Prevention, 2025 update (2025); 2020 Focused Updates to the Asthma Management Guidelines: A Report from the National Asthma Education and Prevention Program Coordinating Committee Expert Panel Working Group (2020); CMID: Clinical Monitoring Intelligence Database, asthma monograph (2026)
Follow-up: Nurse telephone check in three days. Clinic review within one week. Return the same day or go to the emergency department for red-zone symptoms. Next scheduled visit 2026-09-14: six-month asthma review after a summer exacerbation. [S]